CDEK
← All organizations

Rexahn Pharmaceuticals, Inc.

For profitWebsite ↗
Phase 1Phase 2Phase 3Phase 4

First clinical trial

Jun 1, 2008

Last known activity

Jun 1, 2017

Acquired by Ocuphire Pharma, Inc. → Rexahn Pharmaceuticals, Inc. → Ocuphire Pharma, Inc. → Rexahn Pharmaceuticals, Inc. → Ocuphire Pharma, Inc. → Rexahn Pharmaceuticals, Inc. → Ocuphire Pharma, Inc. → Rexahn Pharmaceuticals, Inc. → Ocuphire Pharma, Inc. → Rexahn Pharmaceuticals, Inc. → Ocuphire Pharma, Inc. → Rexahn Pharmaceuticals, Inc. → Ocuphire Pharma, Inc. → Rexahn Pharmaceuticals, Inc. → Ocuphire Pharma, Inc. → Rexahn Pharmaceuticals, Inc. → Ocuphire Pharma, Inc. → Rexahn Pharmaceuticals, Inc. → Ocuphire Pharma, Inc. → Rexahn Pharmaceuticals, Inc. → Ocuphire Pharma, Inc. → Rexahn Pharmaceuticals, Inc. → Ocuphire Pharma, Inc. → Rexahn Pharmaceuticals, Inc. → Ocuphire Pharma, Inc. on Jun 19, 2020

Timeline

2000s

  1. Jun 1, 2001

    Rexahn Pharmaceuticals, Inc.— Founded

2020s

  1. Jun 18, 2020

    Ocuphire Pharma, Inc.— Acquired

  2. Jun 19, 2020

    Ocuphire Pharma, Inc.— Acquired By

  3. Jun 19, 2020

    Ocuphire Pharma, Inc.— Now

Drugs by trial phase (9 distinct, 21 trials)

Phase 3 (0 own, 2 via acquisition)

Phase 1 (0 own, 1 via acquisition)

Indications

Studied for

Subsidiaries (1 direct, 25 total across the full acquisition tree)

Recent trials (15)

Details

Founded
Rockville, MD, US Jun 1, 2001
Last known activity
Jun 1, 2017